Cerity Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
56,916
-1,637
-3% -$58.1K ﹤0.01% 1540
2025
Q4
$2.11M Buy
58,553
+4,868
+9% +$179K ﹤0.01% 1353
2025
Q3
$1.69M Sell
53,685
-6,235
-10% -$224K ﹤0.01% 1366
2025
Q2
$2.55M Sell
59,920
-5,464
-8% -$227K ﹤0.01% 1102
2025
Q1
$2.92M Buy
65,384
+5,988
+10% +$322K 0.01% 956
2024
Q4
$2.85M Sell
59,396
-8,192
-12% -$415K 0.01% 951
2024
Q3
$2.86M Buy
67,588
+37,311
+123% +$1.78M 0.01% 935
2024
Q2
$1.39M Sell
30,277
-4,017
-12% -$189K ﹤0.01% 1080
2024
Q1
$1.78M Buy
+34,294
New +$1.5M ﹤0.01% 1022
2023
Q2
Sell
-2,560
Closed -$391K 1959
2023
Q1
$391K Buy
+2,560
New +$74.2K ﹤0.01% 1410

Other funds holding VCEL

Cerity Partners's VCEL Position: Q1 2026 in Review

Cerity Partners reduced its Vericel Corp (VCEL) stake by 2.8% in Q1 2026, selling an estimated $58.1K and leaving 56,916 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Cerity Partners first reported a position in VCEL in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.92M in Q1 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Cerity Partners held 56,916 shares of Vericel Corp worth $1.83M as of Q1 2026.
  • Cerity Partners sold 1,637 Vericel Corp shares in Q1 2026, an estimated $58.1K.
  • Vericel Corp made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1540 holding.
  • Cerity Partners first reported a position in Vericel Corp in Q1 2023 and has held it in 10 quarters since.
  • Cerity Partners's Vericel Corp position peaked at $2.92M in Q1 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.